Suppr超能文献

通过质谱法对 E1、泛素样蛋白和 Nedd8-MLN4924 加合物进行绝对定量。

Absolute quantification of E1, ubiquitin-like proteins and Nedd8-MLN4924 adduct by mass spectrometry.

机构信息

Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA 02139, USA.

出版信息

Cell Biochem Biophys. 2013 Sep;67(1):139-47. doi: 10.1007/s12013-013-9625-5.

Abstract

Ubiquitin (Ub) and ubiquitin-like (Ubl) proteins regulate a variety of important cellular processes by forming covalent conjugates with target proteins or lipids. Ubl conjugation is catalyzed by a cascade of proteins including activating enzymes (E1), conjugating enzymes (E2), and in many cases ligation enzymes (E3). The discovery of MLN4924 (Brownell et al., Mol Cell 37: 102-111, 1), an investigational small molecule that is a mechanism-based inhibitor of NEDD8-activating enzyme (NAE), reveals a promising strategy of targeting E1/Ubl pathway for therapeutic purposes. In order to better understand, the biochemical dynamics of Ubl conjugation in cells and tissues, we have developed a mass spectrometry-based method to quantify E1 and Ubls using isotope-labeled proteins as internal standards. Furthermore, we have used the described method to quantify levels of the covalent Nedd8-inhibitor adduct formed in MLN4924 treated cells and tissues. The Nedd8-MLN4924 adduct is a tight-binding inhibitor of NAE, and its cellular concentration represents an indirect pharmacodynamic readout of NAE/Nedd8 pathway inhibition.

摘要

泛素 (Ub) 和泛素样 (Ubl) 蛋白通过与靶蛋白或脂质形成共价缀合物来调节各种重要的细胞过程。Ubl 缀合由一系列蛋白催化,包括激活酶 (E1)、连接酶 (E2),在许多情况下还包括连接酶 (E3)。MLN4924(Brownell 等人,Mol Cell 37: 102-111, 1)的发现揭示了一种有前途的针对 E1/Ubl 途径的治疗策略,该小分子是一种 NEDD8-激活酶 (NAE) 的基于机制的抑制剂。为了更好地理解细胞和组织中 Ubl 缀合的生化动力学,我们开发了一种基于质谱的方法,使用同位素标记的蛋白作为内标来定量 E1 和 Ubl。此外,我们还使用所述方法来定量 MLN4924 处理的细胞和组织中形成的共价 Nedd8 抑制剂加合物的水平。Nedd8-MLN4924 加合物是 NAE 的强结合抑制剂,其细胞浓度代表 NAE/Nedd8 途径抑制的间接药效学读数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验